Expression of the CD40 antigen on normal endothelial cells and in benign and malignant tumours of vascular origin

Histopathology

Volumn 29, Issue 6, 1996, Pages 517-524

  Pammer, J ^a   Weninger, W ^a   Mazal, P R ^a,b   Horvat, R ^a   Tschachler, E ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

CD40; Endothelium; Vascular tumours

Indexed keywords

CD40 ANTIGEN; CELL ADHESION MOLECULE;

ANGIOSARCOMA; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMANGIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHANGIOMA; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD40; CARCINOMA; ENDOTHELIUM; ENDOTHELIUM, LYMPHATIC; ENDOTHELIUM, VASCULAR; FETUS; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; NEOPLASMS, VASCULAR TISSUE;

EID: 0030462038     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.d01-531.x     Document Type: Article

References (31)

1. Banchereau J, Bazan F, Blanchard D et al. The CD40 antigen and its ligand. Ann. Rev. Immunol. 1994; 12; 881-922.
2. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 76; 959-962.
3. Paulie S, Ehlin-Henriksson B, Mellstedt H, Koho H, Ben-Aissa H, Perlman B. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol. Immunother. 1985; 20; 23-28.
4. Alderson MR, Armitage R, Tough TW, Strockbine L, Fanslow WC, Spriggs M. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD4. Exp. Med. 1993; 178; 669-674.
5. Caux C, Massacrier C, Vanbervliet B et al. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 1994; 180; 1263-1272.
6. Yellin MJ, Winikoff S, Fortune SM et al. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) upregulation and IL-6 production and proliferation. J. Leukocyt. Biol. 1995; 58; 209-216.
7. Galy AHM, Spitz H. CD40 is functionally expressed on human thymic epithelial cells. J. Immunol 1992; 149; 775-782.
8. Zong YS, Lin H, Choy DTK et al. Nasopharyngeal carcinoma and lymphoinfiltration. Oncology 1991; 48; 290-296.
9. Young LS, Dawson CW, Brown KW, Rickinson AB. Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int. J. Cancer 1989; 43; 786-794.
10. Kanitakis J, Zambruno G, Roche P et al. CD40 antigen expression in normal and diseased human skin J. Invest. Dermatol. 1991; 96; 646 A.
11. Armitage RJ, Fanslow WC, Strockbine L et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357; 80-82.
12. Gauchat JF, Henchoz S, Mazzei G et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365; 340-343.
13. Liu YJ, Mason DY, Johnson GD et al. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol. 1991; 21; 1905-1910.
14. Choi MSK, Boise LH, Gottschalk AR, Quintans J, Thompson CB, Klaus GGB. The role of bcl-xL-mediated rescue from anti-μ-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 1995; 25; 1352-1357.
15. Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-a, but strongly inhanced by interleukin-10. Eur. J. Immunol. 1995; 25; 1943-1950.
16. Möller P, Mielke B. Extensive analysis of tissue distribution of antigens defined by new clustered and unclustered B-cell antibodies. In Knapp W, Dörken B, Gilks WR et al. eds. Leukocyte typing IV. White cell differentiation antigens. Oxford, Oxford University Press. 1989 175-177.
17. Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober JS. CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 1995; 92; 4342-4346.
18. Hollenbaugh D, Mischel-Petty N, Edwards CP et al. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 1995; 182; 33-40.
19. Yellin MJ, Brett J, Baum D et al. Functional interaction of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 1995; 182; 1857-1864.
20. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of Kaposi's sarcoma spindle cells. J. Clin. Invest. 1995; 95; 1723-1724.
21. Roth WK, Brandstetter H, Stürzl M. Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 1992; 6; 895-913.
22. Pammer J, Plettenberg A, Weninger W et al. The CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am. J. Pathol. 1996; 148; 1387-1396.
23. Webster GF, Cockerell CJ, Friedman-Kien. The clinical spectrum of bacillary angiomatosis. Br. J. Dermatol. 1992; 126; 535-541.
24. Sankey EA, More L, Dhillon A P. QBEnd/10: A new immunostain for the routine diagnosis of Kaposi's sarcoma. J. Pathology 1990; 161; 267-271.
25. Russel DS, Rubinstein LJ. Pathology of tumors of the nervous system: Tumors of vascular origin. London: Edward Arnold, 1989 639-663.
26. Spence AM, Rubinstein LJ. Cerebellar capillary hemangioblastoma: its histogenesis studied by organ culture and electron microscopy. Cancer 1975; 35; 326-341.
27. Shea CR, Prieto VG. Mast cells in angiolipomas and hemangiomas of human skin: are they important for angiogenesis? J. Cutan. Pathol. 1994; 21; 247-251.
28. Ho KL. Ultrastructure of cerebellar capillary hemangioblastoma. II. Mast cells and angiogenesis. Acta Neuropathol. (Berl). 1984; 64; 308-318.
29. Reed JA, Albino AP, McNutt NS. Human cutaneous mast cells express basic fibroblast growth factor. Lab. Invest. 1995; 72; 215.
30. Harvima IT, Horsmanheimo L, Naukkarinen A, Horsmanheimo L. Mast cell proteinases and cytokines in skin inflammation. Arch. Dermatol. Res. 1994; 287; 61-67.
31. Plettenberg A, Tronnier M, Kreusch J, Wolff HH, Meigel W. Bazilläre Angiomatose. Hautarzt 1995; 46; 39-43.